TCL Archive Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing November 1, 2012
TCL Archive White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns. September 30, 2005
TCL Archive Advisors approve set-aside for alternative medicine “best case series.” November 19, 2004
TCL Archive Biological Modifiers Journal Objects To NEJ Policy, Says It Will OK Clinical Data Release April 26, 1985
TCL Archive WHI Investigators Reiterate: Breast Cancer, CHD Risks Too Great For Routine HT Use November 2, 2002